Your browser doesn't support javascript.
loading
Time to initiation of lipid-lowering drugs for subclinical atherosclerosis: sub-study of VIPVIZA randomized controlled trial, with single-arm cross-over.
Holmberg, Henrik; Sjölander, Maria; Glader, Eva-Lotta; Näslund, Ulf; Carlberg, Bo; Norberg, Margareta; Själander, Anders.
Afiliación
  • Holmberg H; Department of Public Health and Clinical Medicine, Umeå University, 907 36 Umeå, Sweden.
  • Sjölander M; Department of Integrative Medical Biology, Umeå University, 907 36 Umeå, Sweden.
  • Glader EL; Department of Public Health and Clinical Medicine, Umeå University, 907 36 Umeå, Sweden.
  • Näslund U; Department of Public Health and Clinical Medicine, Umeå University, 907 36 Umeå, Sweden.
  • Carlberg B; Department of Public Health and Clinical Medicine, Umeå University, 907 36 Umeå, Sweden.
  • Norberg M; Department of Public Health and Clinical Medicine, Umeå University, 907 36 Umeå, Sweden.
  • Själander A; Department of Public Health and Clinical Medicine, Umeå University, 907 36 Umeå, Sweden.
Eur Heart J Open ; 2(1): oeac003, 2022 Jan.
Article en En | MEDLINE | ID: mdl-35919662
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Tipo de estudio: Clinical_trials / Guideline Idioma: En Revista: Eur Heart J Open Año: 2022 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Tipo de estudio: Clinical_trials / Guideline Idioma: En Revista: Eur Heart J Open Año: 2022 Tipo del documento: Article